| Literature DB >> 27430316 |
Carolyn E Schwartz1,2, Michael G Dwyer3,4, Ralph Benedict5, Bianca Weinstock-Guttman5, Niels P Bergsland3,6,7, Jei Li8,9, Murali Ramanathan5,10, Robert Zivadinov3,5,11.
Abstract
BACKGROUND: To examine whether past and current reserve-related activities make the brain less susceptible to MS pathology (i.e., lesions or disease-related atrophy).Entities:
Mesh:
Year: 2016 PMID: 27430316 PMCID: PMC4949926 DOI: 10.1186/s12883-016-0624-1
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Study participant demographics
| Variable | HC | CIS | RRMS | SPMS | Test Statistic |
|
|
|---|---|---|---|---|---|---|---|
| N | 276 | 65 | 352 | 109 | |||
| Gender: % female | 60.87 | 61.54 | 64.77 | 61.47 | 2.97 | 0.81 | |
| Mean Age (sd) | 46.93 (15.76) | 39.38 (10.99) | 44.17 (10.75) | 53.91 (8.69) | 23.62 | 0.00 | *** |
| Mean Age at Diagnosis (sd) | NA | 36.25 (10.92) | 34.90 (9.41) | 36.21 (10.09) | 1.03 | 0.36 | |
| Median EDSS (IQR) | NA | 1.50 (1–2) | 2 (3–1.5) | 6 (5–6.5) | 24.64 | 0.00 | *** |
| Diease Duration: mean no. years (sd) | NA | 5.65 (3.32) | 13.1 (7.11) | 21.85 (9.10) | 83.61 | 0.00 | *** |
| Range | NA | 3–20 | 2–41 | 5–45 | |||
| Mean Body Mass Index (sd) | 27.31 (5.70) | 27.14 (5.86) | 27.40 (5.93) | 26.10 (6.01) | 1.35 | 0.26 | |
| Employment Status % | 201.79 | 0.00 | *** | ||||
| Full-time | 48.22 | 61.9 | 45.38 | 11.32 | |||
| Part-time | 15.81 | 11.11 | 12.14 | 10.38 | |||
| Homemaker | 3.16 | 7.94 | 3.47 | 4.72 | |||
| Student | 7.91 | 4.76 | 2.02 | 0 | |||
| Unemployed | 8.3 | 6.35 | 6.65 | 5.66 | |||
| Retired | 13.83 | 3.17 | 6.65 | 24.53 | |||
| Disabled | 0 | 3.17 | 21.97 | 41.51 | |||
| Other | 2.77 | 1.59 | 1.73 | 1.89 | |||
| Education % | 30.85 | 0.01 | * | ||||
| High school not completed | 1.99 | 1.59 | 3.78 | 7.55 | |||
| Graduated high school | 15.54 | 12.7 | 17.15 | 21.7 | |||
| Some college/Associate/Technical Degree | 34.66 | 38.1 | 36.05 | 33.96 | |||
| Bachelor’s degree | 25.9 | 30.16 | 23.26 | 19.81 | |||
| Graduate/Post-graduate | 21.91 | 17.46 | 19.77 | 16.98 | |||
| Race % | 39.52 | 0.00 | *** | ||||
| Caucasian | 83.59 | 92.06 | 91.91 | 95.28 | |||
| Hispanic/Latino | 1.56 | 95.24 | 2.02 | 0.94 | |||
| Black/African-American | 8.59 | 98.41 | 4.91 | 2.83 | |||
| Asian | 3.91 | 100 | 0.58 | 0 | |||
| American Indian/Alaska Native | 0.39 | 0 | 0 | 0 | |||
| Other | 1.95 | 0 | 0.58 | 0.94 | |||
| Past reserve-related Activities: Mean (sd) | 6.60 (0.13) | 6.44 (1.76) | 6.27 (2.06) | 5.75 (2.04) | 4.39 | 0.00 | *** |
| Range | 2–10 | 3–10 | 2–10 | 2–10 | |||
| Strenuous reserve-related Activities: Mean (sd) | 1.61 (0.078) | 0.70 (0.67) | 0.64 (0.70) | 0.36 (0.41) | 76.73 | 0.00 | *** |
| Range | 0–5.42 | 0–2.83 | 0–3.23 | 0–1.8 | |||
| Non-Strenuous reserve-related Activities : Mean(sd) | 5.80 (0.16) | 5.18 (2.47) | 5.36 (2.62) | 5.53 (2.84) | 1.64 | 0.18 | |
| Range | 0.5–12.67 | 0–12 | 0–13.5 | 0–12.83 |
ªHC Healthy Control, CIS Clinically Isolated Syndrome, RRMS Relapsing Remitting MS, SPMS Secondary Progressive MS, The F-Statistics and P-values shown are from tests for differences between disease group for the given variable
* p < 0.05; ** p < 0.01; *** p < 0.001
a-c Regression models predicting reserve-related activitiesa
| Dependent Variable: | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2a Past Reserve Building Activities | 2b Strenuous Current reserve-related Activities | 2c Non-Strenuous Current reserve-related Activities | |||||||||
| Predictors | β | t |
| Predictors | β | t |
| Predictors | β | t |
|
| Chronic lesion burden models | |||||||||||
| Age | 0.01 | 0.13 | 0.90 | Age | –0.19 | –3.94 | 0.00 | Age | –0.05 | –0.94 | 0.35 |
| Gender | –0.02 | –0.42 | 0.68 | Gender | –0.07 | –1.72 | 0.09 | Gender | –0.05 | –1.07 | 0.29 |
| Chronic Burden | –0.31 | –1.25 | 0.21 | Chronic Burden | –0.34 | –1.46 | 0.15 | Chronic Burden | 0.20 | 0.82 | 0.41 |
| CIS | 0.01 | 0.08 | 0.94 | CIS | –0.37 | –5.04 | 0.00 | CIS | –0.03 | –0.43 | 0.67 |
| RR | –0.03 | –0.24 | 0.81 | RR | –0.51 | –5.33 | 0.00 | RR | 0.09 | 0.87 | 0.38 |
| PMS | –0.14 | –1.37 | 0.17 | PMS | –0.51 | –5.42 | 0.00 | PMS | 0.13 | 1.32 | 0.19 |
| Chronic X CIS | 0.01 | 0.18 | 0.86 | Chronic X CIS | 0.15 | 2.58 | 0.01 | Chronic X CIS | 0.06 | 1.05 | 0.29 |
| Chronic X RR | 0.17 | 0.85 | 0.39 | Chronic X RR | 0.26 | 1.41 | 0.16 | Chronic X RR | –0.14 | –0.70 | 0.49 |
| Chronic X SPMS | 0.30 | 1.42 | 0.16 | Chronic X SPMS | 0.30 | 1.51 | 0.13 | Chronic X SPMS | –0.17 | –0.83 | 0.41 |
| Adjusted R-squared | 0.00 | Adjusted R-squared | 0.10 | Adjusted R-squared | 0.00 | ||||||
| N | 523 | N | 526 | N | 535 | ||||||
| Active lesion burden models | |||||||||||
| Age | 0.00 | –0.09 | 0.93 | Age | –0.18 | –3.83 | 0.00 | Age | –0.07 | –1.40 | 0.16 |
| Gender | –0.01 | –0.33 | 0.74 | Gender | –0.08 | –1.84 | 0.07 | Gender | –0.04 | –0.88 | 0.38 |
| Active Burden | –0.04 | 0.00 | 1.00 | Active Burden | –11.72 | –0.89 | 0.38 | Active Burden | –4.71 | –0.34 | 0.73 |
| CIS | –0.09 | –0.81 | 0.42 | CIS | –0.48 | –4.95 | 0.00 | CIS | –0.10 | –0.99 | 0.32 |
| RR | –0.17 | –1.09 | 0.28 | RR | –0.75 | –5.39 | 0.00 | RR | –0.10 | –0.67 | 0.50 |
| PMS | –0.22 | –1.55 | 0.12 | PMS | –0.73 | –5.59 | 0.00 | PMS | –0.03 | –0.25 | 0.81 |
| Active X CIS | 0.01 | 0.00 | 1.00 | Active X CIS | 2.81 | 0.9 | 0.37 | Active X CIS | 1.02 | 0.34 | 0.73 |
| Active X RR | 0.01 | 0.00 | 1.00 | Active X RR | 11.42 | 0.89 | 0.38 | Active X RR | 4.56 | 0.34 | 0.73 |
| Active X SPMS | –0.02 | –0.03 | 0.97 | Active X SPMS | 0.51 | 0.84 | 0.40 | Active X SPMS | 0.15 | 0.24 | 0.81 |
| Adjusted R-squared | –0.01 | Adjusted R-squared | 0.09 | Adjusted R-squared | 0.00 | ||||||
| N | 504 | N | 505 | N | 514 | ||||||
| Brain volume models | |||||||||||
| Age | 0.03 | 0.66 | 0.51 | Age | –0.13 | –3.12 | 0.00 | Age | 0.03 | 0.55 | 0.58 |
| Gender | –0.02 | –0.52 | 0.60 | Gender | 0.01 | 0.45 | 0.65 | Gender | –0.01 | –0.32 | 0.75 |
| Brain Volume* | 0.09 | 1.00 | 0.32 | Brain Volume* | 0.22 | 3.08 | 0.00 | Brain Volume* | 0.10 | 1.16 | 0.25 |
| White Matter Vol. | –0.01 | –0.09 | 0.93 | White Matter Vol. | 0.11 | 1.40 | 0.16 | White Matter Vol. | –0.10 | –1.02 | 0.31 |
| CIS | 0.19 | 0.22 | 0.82 | CIS | 0.92 | 1.26 | 0.21 | CIS | 0.32 | 0.39 | 0.70 |
| RR | –0.86 | –1.13 | 0.26 | RR | 0.98 | 1.59 | 0.11 | RR | –0.45 | –0.60 | 0.55 |
| SPMS | 0.72 | 0.97 | 0.33 | SPMS | 1.20 | 1.98 | 0.05 | SPMS | –1.09 | –1.50 | 0.13 |
| Brain Vol X CIS | –0.31 | –0.57 | 0.57 | Brain Vol X CIS | –0.61 | –1.34 | 0.18 | Brain Vol X CIS | –0.12 | –0.23 | 0.82 |
| Brain Vol X RR | –0.04 | –0.09 | 0.93 | Brain Vol X RR | –1.01 | –2.58 | 0.01 | Brain Vol X RR | 0.06 | 0.13 | 0.90 |
| Brain Vol X SPMS | –0.71 | –1.47 | 0.14 | Brain Vol X SPMS | –0.78 | –1.98 | 0.05 | Brain Vol X SPMS | –0.18 | –0.38 | 0.70 |
| WMV X CIS | 0.11 | 0.16 | 0.87 | WMV X CIS | –0.60 | –0.97 | 0.33 | WMV X CIS | –0.25 | –0.40 | 0.69 |
| WMV X RR | 0.86 | 1.25 | 0.21 | WMV X RR | –0.44 | –0.78 | 0.44 | WMV X RR | 0.35 | 0.52 | 0.61 |
| WMV X SPMS | –0.12 | –0.20 | 0.84 | WMV X SPMS | –0.77 | –1.60 | 0.11 | WMV X SPMS | 1.25 | 2.19 | 0.03 |
| Adjusted R-squared | 0.01 | Adjusted R-squared | 0.28 | Adjusted R-squared | 0.00 | ||||||
| N | 732 | N | 759 | N | 757 | ||||||
| Subcortical gray matter volume models | |||||||||||
| Age | 0.03 | 0.74 | 0.46 | Age | –0.15 | –4.11 | 0.00 | Age | –0.01 | –0.19 | 0.85 |
| Gender | –0.02 | –0.43 | 0.67 | Gender | 0.02 | 0.70 | 0.49 | Gender | –0.01 | –0.38 | 0.71 |
| Subcortical Health* | 0.12 | 1.10 | 0.27 | Subcortical Health* | 0.35 | 4.01 | 0.00 | Subcortical Health* | 0.01 | 0.11 | 0.91 |
| Amygdala Vol. | –0.02 | –0.27 | 0.78 | Amygdala Vol. | –0.16 | –2.39 | 0.02 | Amygdala Vol. | 0.06 | 0.81 | 0.42 |
| CIS | 0.00 | –0.01 | 1.00 | CIS | 0.60 | 1.26 | 0.21 | CIS | –0.27 | –0.45 | 0.65 |
| RR | –0.27 | –0.47 | 0.64 | RR | 0.37 | 0.81 | 0.42 | RR | –0.03 | –0.05 | 0.96 |
| SPMS | 0.37 | 0.72 | 0.47 | SPMS | 0.48 | 1.18 | 0.24 | SPMS | 0.05 | 0.11 | 0.91 |
| Subcortical X CIS | 0.04 | 0.06 | 0.95 | Subcortical X CIS | –1.03 | –2.07 | 0.04 | Subcortical X CIS | 0.22 | 0.37 | 0.71 |
| Subcortical X RR | 0.16 | 0.27 | 0.79 | Subcortical X RR | –1.57 | –3.43 | 0.00 | Subcortical X RR | 0.24 | 0.44 | 0.66 |
| Subcortical X SPMS | –0.64 | –1.26 | 0.21 | Subcortical X SPMS | –1.29 | –3.12 | 0.00 | Subcortical X SPMS | –0.03 | –0.06 | 0.95 |
| Amygdala X CIS | –0.06 | –0.17 | 0.87 | Amygdala X CIS | 0.15 | 0.52 | 0.61 | Amygdala X CIS | –0.01 | –0.04 | 0.97 |
| Amygdala X RR | 0.08 | 0.22 | 0.83 | Amygdala X RR | 0.77 | 2.70 | 0.01 | Amygdala X RR | –0.27 | –0.79 | 0.43 |
| Amygdala X SPMS | 0.19 | 0.58 | 0.56 | Amygdala X SPMS | 0.48 | 1.83 | 0.07 | Amygdala X SPMS | –0.04 | –0.12 | 0.90 |
| Adjusted R-squared | 0.01 | Adjusted R-squared | 0.29 | Adjusted R-squared | –0.01 | ||||||
| N | 731 | N | 758 | N | 756 | ||||||
CIS, Clinically Isolated Syndrome, RRMS Relapsing Remitting MS, SPMS Secondary Progressive MS
aInteraction terms are denoted by “X’ between main effect terms in the bottom section of each table. The referent group is healthy controls
Fig. 1a-e Box plots of Maximal Lifetime Brain Growth in RRMS patients. Shown by change in strenuous activity group for aerobics, running, walking, weights, and yoga. On the far left is the box plot for individuals who engaged in the strenuous activity both before and after MS diagnosis. The box plot immediately to the right is for those individuals who engaged only after, then only before, then never. The far right box plot show the distribution on the Maximal Lifetime Brain Growth score for those individuals missing data on that activity
Fig. 2a-e Box plots of Residual Brain Volume in RRMS patients. Shown by change in strenuous activity group for aerobics, running, walking, weights, and yoga. On the far left is the box plot for individuals who engaged in the strenuous activity both before and after MS diagnosis. The box plot immediately to the right is for those individuals who engaged only after, then only before, then never. The far right box plot show the distribution on the Residual Brain Volume score for those individuals missing data on that activity